Eqis Capital Management, Inc. Johnson & Johnson Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

A detailed history of Eqis Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 9,530 shares of JNJ stock, worth $1.47 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

9,530

Previous 10,128 5.9%

Holding current value

$1.47 Million

Previous $1.48 Million 4.32%

% of portfolio

0.13%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $86,997 - $100,093	-598 Reduced 5.9%	9,530 $1.54 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $373,511 - $408,176	-2,587 Reduced 20.35%	10,128 $1.48 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $111,758 - $117,172	-720 Reduced 5.36%	12,715 $2.01 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $788,424 - $860,335	-5,415 Reduced 28.73%	13,435 $2.11 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $1.56 Million - $1.75 Million	-10,018 Reduced 34.7%	18,850 $2.94 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $117,306 - $126,243	-760 Reduced 2.57%	28,868 $4.78 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $419,465 - $500,582	-2,777 Reduced 8.57%	29,628 $4.59 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $384,159 - $431,136	-2,398 Reduced 6.89%	32,405 $5.72 Million
Q3 2022 Oct 24, 2022	SELL	$161.33 - $179.52 $46,947 - $52,240	-291 Reduced 0.83%	34,803 $5.69 Million
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $212,760 - $235,302	-1,265 Reduced 3.48%	35,094 $6.23 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $1.67 Million - $1.89 Million	10,548 Added 40.87%	36,359 $6.44 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $261,806 - $290,483	-1,679 Reduced 6.11%	25,811 $4.42 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $223,354 - $248,207	1,383 Added 5.3%	27,490 $4.44 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $266,172 - $285,515	-1,669 Reduced 6.01%	26,107 $4.3 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $472,833 - $526,612	-3,089 Reduced 10.01%	27,776 $4.57 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $95,977 - $110,166	700 Added 2.32%	30,865 $4.86 Million
Q3 2020 Nov 10, 2020	BUY	$140.38 - $153.83 $173,930 - $190,595	1,239 Added 4.28%	30,165 $4.49 Million
Q2 2020 Aug 10, 2020	BUY	$128.81 - $155.51 $427,778 - $516,448	3,321 Added 12.97%	28,926 $4.07 Million
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $142,370 - $197,261	1,281 Added 5.27%	25,605 $3.89 Million
Q4 2019 Jan 24, 2020	BUY	$127.5 - $146.44 $77,137 - $88,596	605 Added 2.55%	24,324 $3.55 Million
Q3 2019 Nov 05, 2019	BUY	$126.95 - $142.14 $288,557 - $323,084	2,273 Added 10.6%	23,719 $3.07 Million
Q2 2019 Jul 18, 2019	BUY	$131.15 - $144.24 $318,432 - $350,214	2,428 Added 12.77%	21,446 $2.99 Million
Q1 2019 Apr 18, 2019	BUY	$125.72 - $139.79 $378,668 - $421,047	3,012 Added 18.82%	19,018 $2.66 Million
Q4 2018 Jan 25, 2019	SELL	$122.84 - $147.84 $405,494 - $488,019	-3,301 Reduced 17.1%	16,006 $2.07 Million
Q3 2018 Oct 17, 2018	SELL	$121.58 - $142.88 $166,807 - $196,031	-1,372 Reduced 6.63%	19,307 $2.58 Million
Q2 2018 Jul 27, 2018	SELL	$119.4 - $131.76 $559,389 - $617,295	-4,685 Reduced 18.47%	20,679 $2.51 Million
Q1 2018 Apr 06, 2018	SELL	$125.1 - $148.14 $303,117 - $358,943	-2,423 Reduced 8.72%	25,364 $3.25 Million
Q4 2017 Jan 25, 2018	BUY	$131.22 - $143.62 $377,782 - $413,481	2,879 Added 11.56%	27,787 $3.88 Million
Q3 2017 Oct 03, 2017	BUY	$129.47 - $135.38 $3.22 Million - $3.37 Million	24,908	24,908 $3.24 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account

Eqis Capital Management, Inc. Johnson & Johnson Transaction History